CIC
AMGN icon

Chase Investment Counsel’s Amgen AMGN Stock Holding History

Chase Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,709
Closed -$601K – 139
2026
Q1 		$601K Hold
1,709
– – 0.16% 99
2025
Q4 		$559K Sell
1,709
-68
-4% -$21.6K 0.16% 92
2025
Q3 		$501K Sell
1,777
-102
-5% -$29.6K 0.15% 98
2025
Q2 		$524K Buy
1,879
+317
+20% +$89.8K 0.17% 90
2025
Q1 		$486K Sell
1,562
-7
-0.4% -$2.07K 0.18% 90
2024
Q4 		$408K Sell
1,569
-5
-0.3% -$1.48K 0.13% 105
2024
Q3 		$507K Buy
1,574
+25
+2% +$8.18K 0.17% 90
2024
Q2 		$483K Buy
1,549
+121
+8% +$35.5K 0.17% 94
2024
Q1 		$406K Buy
1,428
+87
+6% +$25.5K 0.15% 105
2023
Q4 		$386K Buy
+1,341
New +$365K 0.17% 100
2016
Q4 		– Sell
-29,193
Closed -$4.87M – 92
2016
Q3 		$4.87M Buy
+29,193
New +$4.94M 2.15% 16

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Chase Investment Counsel's AMGN Position: Q2 2026 in Review

Chase Investment Counsel sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,709 shares — an estimated $601K sold.

Chase Investment Counsel first reported a position in AMGN in Q3 2016 and held it in 11 quarters. The position peaked at $4.87M in Q3 2016. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Chase Investment Counsel reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Chase Investment Counsel sold 1,709 Amgen shares in Q2 2026, an estimated $601K.
  • Chase Investment Counsel first reported a position in Amgen in Q3 2016 and held it in 11 quarters.
  • Chase Investment Counsel's Amgen position peaked at $4.87M in Q3 2016.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.